Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Completion of Foundation-sponsored Ataxia Clinical Training (ACT) Program Improves Fellows’ Competence and Confidence in Ataxia Care and Diagnosis
Education, Research, and Methodology
P3 - Poster Session 3 (5:30 PM-6:30 PM)
7-002

Ataxias are a group of rare, heterogeneous movement disorders that are challenging to diagnose and lack treatment options. Despite over 200 forms of ataxia-related disorders, clinical training for ataxias is highly variable and often minimal within fellowship training programs. To address educational gaps in medical training, the National Ataxia Foundation (NAF) developed an in-person educational program to expand exposure of neurology fellows to ataxia clinical care.

The Ataxia Clinical Training (ACT) program aims to educate movement disorders, genetics, and neuromuscular fellows on the diagnostic investigation and treatment of ataxias.

Thirty-six fellows attended a live, 3-day ataxia-focused training program in March 2023. The program included interactive clinical training sessions with ataxia patients and a series of didactic lectures by ataxia clinical experts on the diagnosis and comprehensive care of ataxic disorders. Fellows were required to take a test developed by ACT lecturers before and after the program to assess learnings, as well as complete a survey focused on their clinical exposure to ataxias prior to attending the meeting and their perspective on ACT impacts on their future practice.

Over 70% of attendees reported exposure to <20 ataxia patients prior to ACT. Fellows achieved an overall improvement of 18% in test scores after completion of the ACT program. In addition, 93% of attendees reported that the course had (1) better prepared them to diagnose and treat ataxias in the future, and (2) will impact their future care strategies. Finally, 73% indicated an interest in pursuing future opportunities in ataxia care and research.

Based on survey results and learning assessments, the first live ACT program achieved its goal of improving comprehension and confidence of neurology fellows in the treatment of ataxic disorders.

Authors/Disclosures
Lauren Moore, PhD (National Ataxia Foundation)
PRESENTER
Dr. Moore has nothing to disclose.
Beth Bowerman (National Ataxia Foundation) No disclosure on file
Pravin Khemani, MD, FAAN (Swedish Neuroscience Institute) Dr. Khemani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Khemani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cala Trio. Dr. Khemani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine.
Aimee Alcott No disclosure on file
Kelsey Trace, OTD (National Ataxia Foundation) Dr. Trace has received personal compensation for serving as an employee of National Ataxia Foundation.